Effect of PET before liver resection on surgical management for colorectal adenocarcinoma metastases a randomized clinical trial

JAMA

Volumn 311, Issue 18, 2014, Pages 1863-1869

  Moulton, Carol Anne ^a   Gu, Chu Shu ^b   Law, Calvin H ^c   Tandan, Ved R ^b   Hart, Richard ^d   Quan, Douglas ^e   Fairfull Smith, Robert J ^f   Jalink, Diederick W ^g   Husien, Mohamed ^h   Serrano, Pablo E ^a   Hendler, Aaron L ^a   Haider, Masoom A ^c   Ruo, Leyo ^b   Gulenchyn, Karen Y ^b   Finch, Terri ^b   Julian, Jim A ^b   Levine, Mark N ^b   Gallinger, Steven ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d ST JOSEPH S HEALTH CENTRE   (Canada)

^e LONDON HEALTH SCIENCES CENTRE   (Canada)

^f UNIVERSITY OF OTTAWA   (Canada)

^g KINGSTON GENERAL HOSPITAL   (Canada)

^h Grand River Regional Cancer Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL RADIOGRAPHY; ADULT; AGED; ARTICLE; CANADA; CANCER PROGNOSIS; CANCER SURGERY; CLINICAL EFFECTIVENESS; COLONOSCOPY; COLORECTAL CARCINOMA; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LAPAROTOMY; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OVERALL SURVIVAL; PATIENT IDENTIFICATION; PELVIS RADIOGRAPHY; PERITONEAL CAVITY; PET-CT SCANNER; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; THORAX RADIOGRAPHY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PREOPERATIVE CARE; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84900310367     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.3740     Document Type: Article

References (25)

1. Al-Asfoor A, Fedorowicz Z, Lodge M. Resection versus no intervention or other surgical interventions for colorectal cancer liver metastases. Cochrane Database Syst Rev. 2008;(2):CD006039.
2. Shah SA, Bromberg R, Coates A, et al. Survival after liver resection for metastatic colorectal carcinoma in a large population. J AmColl Surg. 2007;205(5):676-683. (Pubitemid 47615495)
3. Robertson DJ, Stukel TA, Gottlieb DJ, et al. Survival after hepatic resection of colorectal cancer metastases. Cancer. 2009;115(4):752-759.
4. Nanji S, Cleary S, Ryan P, et al. Up-front hepatic resection for metastatic colorectal cancer results in favorable long-term survival [published correction appears in Ann Surg Oncol. 2013;20(suppl 3):S751]. Ann Surg Oncol. 2013;20(1):295-304.
5. Rees M, Tekkis PP, Welsh FK, et al. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer. Ann Surg. 2008;247(1):125-135.
6. Pulitanò C, Bodingbauer M, Aldrighetti L, et al. Liver resection for colorectalmetastases in presence of extrahepatic disease. Ann Surg Oncol. 2011;18(5):1380-1388.
7. Flamen P, Stroobants S, Van Cutsem E, et al. Additional value of whole-body positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D- glucose in recurrent colorectal cancer. J Clin Oncol. 1999;17(3):894-901. (Pubitemid 29109320)
8. Valk PE, Abella-Columna E, Haseman MK, et al. Whole-body PET imaging with [18F]fluorodeoxyglucose in management of recurrent colorectal cancer. Arch Surg. 1999;134(5):503-513. (Pubitemid 29218121)
9. Arulampalam TH, Francis DL, Visvikis D, et al. FDG-PET for the pre-operative evaluation of colorectal liver metastases. Eur J Surg Oncol. 2004;30(3):286-291. (Pubitemid 38425646)
10. Kantorová I, Lipská L, Bêlohlávek O, et al. Routine (18)F-FDG PET preoperative staging of colorectal cancer. J Nucl Med. 2003;44(11):1784-1788.
11. Desai DC, Zervos EE, Arnold MW, et al. Positron emission tomography affects surgical management in recurrent colorectal cancer patients. Ann Surg Oncol. 2003;10(1):59-64.
12. Strasberg SM, Dehdashti F, Siegel BA, et al. Survival of patients evaluated by FDG-PET before hepatic resection for metastatic colorectal carcinoma. Ann Surg. 2001;233(3):293-299. (Pubitemid 32187806)
13. Adam R, de Haas RJ, Wicherts DA, et al. Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement? J Clin Oncol. 2008;26(22):3672-3680.
14. Maziak DE, Darling GE, Inculet RI, et al. Positron emission tomography in staging early lung cancer: a randomized trial. Ann Intern Med. 2009;151(4):221-228,W-48.
15. Evans WK, Laupacis A, Gulenchyn KY, et al. Evidence-based approach to the introduction of positron emission tomography in ontario, Canada. J Clin Oncol. 2009;27(33):5607-5613.
16. Young H, Baum R, Cremerius U, et al. Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography. Eur J Cancer. 1999;35(13):1773-1782. (Pubitemid 29512308)
17. Charnsangavej C, Clary B, Fong Y, et al. Selection of patients for resection of hepatic colorectalmetastases. Ann Surg Oncol. 2006;13(10):1261- 1268. (Pubitemid 44435791)
18. Carpizo DR, Are C, Jarnagin W, et al. Liver resection for metastatic colorectal cancer in patients with concurrent extrahepatic disease. Ann Surg Oncol. 2009;16(8):2138-2146.
19. Wiering B, Krabbe PF, Jager GJ, et al. The impact of fluor-18- deoxyglucose-positron emission tomography in the management of colorectal liver metastases. Cancer. 2005;104(12):2658-2670. (Pubitemid 41798276)
20. Ruers TJ, Wiering B, van der Sijp JR, et al. Improved selection of patients for hepatic surgery of colorectal liver metastases with (18)F-FDG PET. J Nucl Med. 2009;50(7):1036-1041.
21. Akhurst T, Kates TJ, Mazumdar M, et al. Recent chemotherapy reduces the sensitivity of [18F]fluorodeoxyglucose positron emission tomography in the detection of colorectal metastases. J Clin Oncol. 2005;23(34):8713-8716. (Pubitemid 46211515)
22. McGlynn EA, Asch SM, Adams J, et al. The quality of health care delivered to adults in the United States. N Engl J Med. 2003;348(26):2635-2645. (Pubitemid 36741592)
23. Hu YY, Kwok AC, Jiang W, et al. High-cost imaging in elderly patients with stage IV cancer. J Natl Cancer Inst. 2012;104(15):1164-1172.
24. Rowan K. Rising costs of medical imaging spur debate. J Natl Cancer Inst. 2008;100(23):1665-1667.
25. Institute of Medicine. Initial National Priorities for Comparative Effectiveness Research: Report Brief. Washington, DC: Institute of Medicine of the National Academies; 2009.